Price Adjustments for 14 Categories of Medical Consumables Trigger Nationwide Reforms
Medtronic
Medical Device Manufacturer
Johnson & Johnson
Medical Device R&D and Manufacturer
Reproduction without authorization is prohibited, and reproduction is allowed only 24 hours later!
Price Regulation of Consumables Listed in Multiple Provinces Resumes Again.
Today (November 7th)），Zhejiang ProvinceThe Medical Insurance Bureau released the "Notice on Carrying Out the 2025 Zhejiang Province Medical Consumables Centralized Procurement Online Transaction Product Price Linkage Work"，Prices of 14 categories of consumables and reagents face adjustment.
The notice clearly states that thisThe linked price range is the provincial online listing price (excluding centralized volume procurement)., the linked price to be reported must be"Minimum Value" within the Price Linkage Range。
The specific product range includes:Cardiac (Coronary) Interventional, Peripheral Vascular Interventional, Cardiac Pacemakers, Electrophysiology, Polymer Materials, Orthopedic, General Surgery, Non-Vascular Interventional (Endoscopic Consumables), Neurosurgery, Blood Purification and Extracorporeal Circulation, Ophthalmology, Cardiothoracic Surgery, Anesthesia, COVID-19 Testing Related Reagents14 categories of consumables (excluding centralized bulk procurement items).
It is worth mentioning that, if the product provision is foundFalse InformationOr should be provided butNot providedAfter verification, the following rules will be applied.
①If a company has the same category, thenExistenceTwo or fewer，The corresponding products will be based on the linked price.Reduce by another 5%；
②Exist3 to 5 (inclusive), thenA Further 10% Reduction；
③Exist6 or moreProducts with inaccurate reporting of linked prices,All products in this category from the company will be suspended from online trading.
The time for this price linkage filing is from November 10, 2025, to November 24, 2025. A "list of involved production (supply) enterprises" has been issued along with the notice.Medtronic, Johnson & Johnson, Stryker, and more than a thousand other production and supply companies are affected.
Coincidentally, on November 5,Jiangxi ProvinceThe National Healthcare Security Administration released the "Notice on the Normalization of Price Linkage for Medical Consumables Listed on the Procurement Platform," which also willOther than the centralized procurementAllMedical consumables (including in vitro diagnostic reagents) listed on the procurement platform, included in the scope of routine price linkage.
Jiangxi Province requires,Medical consumables registered on the platform in other provinces (autonomous regions, municipalities)After generating a lower online price，Enterprises shouldVoluntarily declare and reduce the online price limit within 30 natural days., Failure to declare on time will result in"Discretionary Benchmark for Medical Price and Procurement Credit Evaluation (2025 Edition)" relevant regulations apply.
Current Market，Despite regional differences in the progress of price reductions for some products，ButGenerally, a three-dimensional supervision network for the governance of medical consumables prices has been formed in China.. The centralized procurement of consumables was the first to break the original price pattern, while the price linkage mechanism further built up a price regulation network covering the whole of China. Through the interconnection of cross-provincial price information, it continuously squeezed the space of excessively high prices, and all of these are the best manifestations of national policy adjustments.
And to further promote the establishment of a unified "one chessboard" pattern for the national listing of consumables, at the beginning of this year, the National Medical Security Administration released the "First Batch of Key Tasks List for 2025 in the Field of Medical Insurance to 'Efficiently Accomplish One Task'", which clearly proposedThe requirement of "National Joint Review and Interconnection of Medical Product Listings" actively promotes the interconnection of price information between provinces.
Under this policy framework,The comprehensive management of consumable prices across China has been fully launched.
Since 2025, multiple provinces across China have been issuing policies for dynamic price adjustments of medical consumables. Except for Jiangxi Province,Shandong, Hubei, Hainan, Heilongjiang, Anhui, Qinghai, and GuangdongProvinces such as [...] have all issued documents to clarify,When the online-listed products hit a new low price in China, enterprises are required to complete the price declaration adjustment within 30 days.
Hunan ProvinceThe Notice on Regulating the Sunshine Listing and Procurement of Medical Consumables (Trial) will be officially implemented from September 1. The new regulations not only require companies to complete adjustments within 30 days when new low prices for consumables listed in other provinces or record-filing products meet the conditions for linkage listing, but also innovatively establish..."Procurement Price Alert Threshold" Mechanism。
Under this mechanism, whenWhen the actual transaction price of a product is less than 50% of the listed price, and the proportion of low-price purchases exceeds 20% within 90 daysCompanies must reduce the listed price to the average of the actual transaction price or 80% of the listed price (whichever is lower).Otherwise, it will face suspension from online listing.
Hubei, Hainan, AnhuiFocus on cross-provincial and national price linkageWhen the price of a product listed on other provincial procurement platforms is lower than the lowest listing (winning bid) price on the Hubei platform (excluding volume-based procurement selection prices), enterprises must declare and update the new price within 30 days from the implementation date of the new low price.
Heilongjiang ProvinceImpose the same disciplinary measures as in Jiangxi,Clarify that when a new low price appears for a product listed online, the company must complete price maintenance within 30 days.Products that fail to be declared within the deadline will be suspended from online listing for 1 year., and handle it according to the "Discretionary Benchmark for Price and Procurement Credit Evaluation in the Pharmaceutical Industry."
Qinghai ProvinceImplementing EnterpriseA Model Combining Active Reporting with Platform Dynamic Management, requiring enterprises to monitor the changes in the online listing prices of their province in real time and submit an adjustment application to the provincial drug procurement center within 30 days to ensure timely and efficient price linkage.Guangdong ProvinceRelying on the whole countryList PriceList of Specifications,By combining data sharing with enterprise reporting, regularly link up with low prices from outside the province that have been posted online to form a normalized price adjustment mechanism.
Past, due toSignificant price differences exist among medical consumables of different types and in different regions., the market price system is relatively chaotic. And with the linkage of the prices of online listed consumables,Price adjustments across regions will create synergistic effects, effectively narrowing the price gap between regions.。
It can be foreseen that, in the future, with the assistance of intelligent regulation,Price monitoring and linkage will achieve more real-time and precise data interaction, allowing price adjustments to more promptly reflect the true market conditions.
